Comments
Loading...

Virtus LifeSci Biotech Products ETF

BBPARCA
Logo brought to you by Benzinga Data
$60.56
0.070.11%
At close: -
Sector
Healthcare
Region
US
AUM
21.41M
Fund Score

Virtus LifeSci Biotech Products ETF (ARCA:BBP) Quotes, Forecast and News Summary

Virtus LifeSci Biotech Products ETF (ARCA: BBP) stock price, news, charts, stock research, profile.

Open$60.49
High$60.56
52 Wk High$69.12
AUM21.41M
Dividend-
Ex-Div Date-
Volume413
Market Cap$19.92B
Mgmt Fee0.79%
P/E Ratio14.96
Prev. Close$60.49
Low$60.49
52 Wk Low$50.43
Shares Out350.00K
Yield-
Div. Freq-
Avg. Volume Daily3.29K
Beta0.63
Avg. Expense Ratio0.79%
P/B Ratio4.03

FAQ

Q

How do I buy Virtus LifeSci Biotech Products ETF (BBP) stock?

A

You can purchase shares of Virtus LifeSci Biotech Products ETF (ARCA:BBP) through any online brokerage.

View our list of the best stock brokerages

Q

Who are Virtus LifeSci Biotech Products ETF (BBP) competitors?

A

There are no as such competitors for Virtus LifeSci Biotech Products ETF.

Q

What is the forecast, or price target, for Virtus LifeSci Biotech Products ETF (BBP) stock?

A

There is no analysis for Virtus LifeSci Biotech Products ETF to provide a consensus price target.

Q

What is the current price for Virtus LifeSci Biotech Products ETF (BBP)?

A

The stock price for Virtus LifeSci Biotech Products ETF (ARCA: BBP) is $60.5558 last updated December 24, 2024 at 5:00 PM EST.

Q

Does Virtus LifeSci Biotech Products ETF (BBP) pay a dividend?

A

A quarterly cash dividend of 0.07 per share of Class A Common Stock. The quarterly cash dividend was payable on December 27, 2017 to stockholders of record on December 20, 2017.

Q

When is Virtus LifeSci Biotech Products ETF (ARCA:BBP) reporting earnings?

A

Virtus LifeSci Biotech Products ETF does not have any upcoming earnings scheduled.

Q

Is Virtus LifeSci Biotech Products ETF (BBP) going to split?

A

There is no upcoming split for Virtus LifeSci Biotech Products ETF.

Open$60.49
High$60.56
52 Wk High$69.12
AUM21.41M
Dividend-
Ex-Div Date-
Volume413
Market Cap$19.92B
Mgmt Fee0.79%
P/E Ratio14.96
Prev. Close$60.49
Low$60.49
52 Wk Low$50.43
Shares Out350.00K
Yield-
Div. Freq-
Avg. Volume Daily3.29K
Beta0.63
Avg. Expense Ratio0.79%
P/B Ratio4.03
ETF Details
SectorHealthcare
CategoryMid Performer-Mid Growth
Investment StyleMid Cap Growth
Fund InceptionDec 16, 2014
Managers
Seth Kadushin
Matthew B. Brown
Andrew McDonald
Paul Yook
DefinitionMost of the stocks in this Equity Fund have average financial performance and average growth potential
Investment Policy
Under normal market conditions, the fund will invest not less than 80% of its assets in component securities of the index. The index seeks to track the performance of the common stock of U.S. exchange-listed biotechnology companies with at least one drug therapy approved by the U.S. Food and Drug Administration (FDA) for marketing.
Top ETF Holdings
SymbolNameShare %
ADMAAdma Biologics Inc Com4.54%
INSMInsmed Inc3.66%
TARSTarsus Pharmaceuticals...3.31%
MRNAModerna therapeutics3.19%
DCPHDeciphera Pharmaceutic...3.10%
AGIOAgios Pharmaceuticals ...3.01%
SRPTSarepta Therapeutics I...2.64%
PTCTPtc Therapeutics Inc2.53%
LXRXLexicon Pharmaceutcl2.51%
BPMCBlueprintmedicines Cor...2.42%